Literature DB >> 3490521

Mechanisms of successful amoxicillin prophylaxis of experimental endocarditis due to Streptococcus intermedius.

P Moreillon, P Francioli, D Overholser, P Meylan, M P Glauser.   

Abstract

Prophylaxis with amoxicillin (40 mg/kg) was studied in rats with aortic valve vegetations. Bacteria on the valves were quantitated early (10 min to 6 hr) and late (three days) after intravenous challenge with tolerant Streptococcus intermedius. Amoxicillin reduced by 40% the number of bacteria per valve 10 min after intravenous challenge with 10(5) S. intermedius (P less than .05) and by 74% the incidence of endocarditis three days thereafter (P less than .0001). Bacterial multiplication started 2 hr after challenge in control rats, whereas bacteria disappeared in 6 hr in amoxicillin-treated rats. Intravenous penicillinase 30 min after challenge abolished successful amoxicillin prophylaxis, a result demonstrating the necessity of prolonged growth inhibition for protection. Growth inhibition for 18 hr (two subsequent amoxicillin doses) was necessary for protection after intravenous challenge with 10(5) S. intermedius. Thus, in the absence of bacterial killing, inhibition of valvular colonization by amoxicillin was not as important a mechanism of endocarditis prophylaxis as was prolonged inhibition of bacterial growth, which allowed adherent bacteria to be cleared from the valves.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3490521     DOI: 10.1093/infdis/154.5.801

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Successful single-dose teicoplanin prophylaxis against experimental streptococcal, enterococcal, and staphylococcal aortic valve endocarditis.

Authors:  G S Perdikaris; A Pefanis; H Giamarellou; A Nikolopoulos; E P Margaris; I Donta; A Tsitsika; P Karayiannakos
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

2.  Antimicrobial prophylaxis of experimental endocarditis caused by Staphylococcus epidermidis.

Authors:  L M Baddour; M M Hill; A M Felty-Duckworth
Journal:  Infection       Date:  1989 Mar-Apr       Impact factor: 3.553

3.  Chemoprophylactic efficacy against experimental endocarditis caused by beta-lactamase-producing, aminoglycoside-resistant enterococci is associated with prolonged serum inhibitory activity.

Authors:  A S Bayer; J Tu
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

4.  Teicoplanin in cardiac surgery: intraoperative pharmacokinetics and concentrations in cardiac and mediastinal tissues.

Authors:  C Martin; P Bourget; M Alaya; A Sertin; C Atlani; K Ennabli; R Said
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

5.  Cost effectiveness of prophylaxis in dental practice to prevent infective endocarditis.

Authors:  I M Gould; J K Buckingham
Journal:  Br Heart J       Date:  1993-07

6.  Successful trovafloxacin prophylaxis against experimental streptococcal aortic valve endocarditis.

Authors:  I Katsarolis; A Pefanis; D Iliopoulos; P Siaperas; P Karayiannakos; H Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

7.  Single-oral-dose azithromycin prophylaxis against experimental streptococcal or staphylococcal aortic valve endocarditis.

Authors:  A Tsitsika; A Pefanis; G S Perdikaris; I Donta; P Karayiannakos; H Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

8.  Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis.

Authors:  D Vermot; J M Entenza; J Vouillamoz; M P Glauser; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

9.  Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcal endocarditis in rats.

Authors:  U Fluckiger; P Moreillon; J Blaser; M Bickle; M P Glauser; P Francioli
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

10.  Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis.

Authors:  J Dankert; J van der Werff; S A Zaat; W Joldersma; D Klein; J Hess
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.